Research graph
References from Use of subcutaneous natalizumab in routine care – Final results of a non-interventional, observational study (SISTER) in Germany and Austria. Local targets link to admitted publications; unresolved targets remain external evidence.
TYSABRI 300 mg concentrate for solution for infusion
External reference
Unresolved reference
External reference
10.1056/nejmoa020696
10.1056/nejmoa020696 · External reference
10.1212/01.wnl.0000260064.77700.fd
10.1212/01.wnl.0000260064.77700.fd · External reference
10.1056/nejmoa044397
10.1056/nejmoa044397 · External reference
10.1136/jnnp-2019-322326
10.1136/jnnp-2019-322326 · External reference
10.1007/s40120-023-00461-0
10.1007/s40120-023-00461-0 · External reference
10.1007/s12325-021-01722-w
10.1007/s12325-021-01722-w · External reference
10.1002/jcph.707
10.1002/jcph.707 · External reference
10.1177/13524585211003020
10.1177/13524585211003020 · External reference
10.1177/17562864241241382
10.1177/17562864241241382 · External reference
10.1016/j.jclinepi.2007.11.008
10.1016/j.jclinepi.2007.11.008 · External reference
10.1016/s1474-4422(17)30470-2
10.1016/s1474-4422(17)30470-2 · External reference
10.1111/j.1524-4733.2005.00066.x
10.1111/j.1524-4733.2005.00066.x · External reference
10.1002/ana.24286
10.1002/ana.24286 · External reference
10.1016/s1474-4422(22)00143-0
10.1016/s1474-4422(22)00143-0 · External reference
10.1007/s40120-024-00647-0
10.1007/s40120-024-00647-0 · External reference
10.1007/s00415-023-11955-0
10.1007/s00415-023-11955-0 · External reference
10.1007/s41669-023-00394-2
10.1007/s41669-023-00394-2 · External reference
10.1056/nejm200006223422506
10.1056/nejm200006223422506 · External reference
10.1056/nejm200006223422507
10.1056/nejm200006223422507 · External reference
10.1186/s12916-021-02176-1
10.1186/s12916-021-02176-1 · External reference
